Howard Wolfe Memorial Fund

A Stem Cell Pioneer Continuing to Help Others.

At the Lung Institute, we love to share the stories of our patients and how we have been able to improve the lives of so many people over the last year. One such story is that of Howard Wolfe—an individual who was helped by the care and treatment of one of our past physicians. With the help of stem cell treatments, Howard and his wife, Susan Wolfe, were allowed several more years together.

Howard was a proud Army NCO (retired) and a long time resident of Mississippi. Happily married for 33 years and a father of three, Howard was diagnosed with chronic obstructive pulmonary disease (COPD)—a disease with no cure— in 1989. In 1990, the disease progressed to a point in which he was forced to retire. He saw a local lung specialist and pursued conventional treatments, but his PFT (pulmonary function test) only declined more at each visit. Once his PFT got down to 12 percent, his doctors put him on hospice care, 8 years ago. Seeking help for his condition, Howard and Susan looked to stem cell therapy to help treat his lung disease.

The Wolfes took part in a three day treatment that introduced stem cells into the lungs though an IV infusion in hopes that it would help improve his lung function. Over the next several years, Howard received multiple stem cell treatments in Florida using his own stem cells from his blood that helped promote healing. His family and friends were impressed by how well he responded to the treatments and believe, to this day, that it gave Howard more time.

“We were shocked by how well the treatments helped Howard,” said Susan. “It definitely gave him several more years.”

Unfortunately, in August 2014, at the age of 75, Howard lost his battle with lung disease. A fund was established between his family and friends to help those who suffer from lung disease and seek stem cell therapy, like Howard Wolfe. The fund is offering to provide copies of the CD Wholetones to Lung Institute patients with the money raised. These CDs are designed to help Lung Institute patients relieve stress, promote healing and break negative cycles, all of which can assist in reducing the symptoms of lung disease.

If you interested in receiving a copy of this CD, talk to a Lung Institute Staff member today.

We are thankful to Susan Wolfe for her amazing donation to the Lung Institute, and we recognize Howard as a true stem cell pioneer continuing to help others today.


  • Susan Wolfe
  • Tony, Patricia, Bart & Matthew Tilley
  • Jeanie McCay
  • Dianne Medley
  • Augusta Waters
  • Nelda Hudgens, Shari Beauchamp, Melba Hollingsworth, Patricia Tilley
  • Joseph & Mary Ware
  • Alma & Alvaro Sandoval
  • Jesalyn Jendrusiak
  • Bonnie Doughty
  • Randy & Kathleen Wolfe
  • Steve & Donna Tucker
  • Larry & Roberta Vanderploeg

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.